This inventor holds 3 USPTO granted patents. Top assignees: Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Pharmaka Mbh, Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2010
Title: Tomoaki Matsumoto: Innovator in Protein Engineering
Introduction
Tomoaki Matsumoto is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of protein engineering, particularly in the development of pharmaceutical compositions for treating cartilage and bone diseases. With a total of 3 patents to his name, Matsumoto's work is recognized for its innovative approach to protein design.
Latest Patents
Matsumoto's latest patents include a protein derived from human MP52, which features an amino acid sequence detailed in SEQ ID No.:1 of the Sequence Listing. This invention describes a homodimer protein that can be obtained through a series of processes, including the construction of a plasmid, transformation, and purification of the protein. The resulting homodimer protein is particularly useful as a pharmaceutical composition aimed at treating cartilage and bone diseases.
Career Highlights
Throughout his career, Matsumoto has worked with Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH, where he has contributed to various biotechnological advancements. His expertise in protein engineering has positioned him as a key figure in the development of innovative therapeutic solutions.
Collaborations
Matsumoto has collaborated with notable colleagues such as Fusao Makishima and Hiroyuki Takamatsu. These partnerships have further enhanced his research and development efforts in the field of biotechnology.
Conclusion
Tomoaki Matsumoto's contributions to protein engineering and his innovative patents highlight his role as a significant inventor in the biotechnology sector. His work continues to pave the way for advancements in pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile